National Research Corporation (NRC)
NASDAQ · Healthcare
National Research Corporation EBITDA 2009–2025
National Research Corporation annual/quarterly ebitda history and growth rate from 2009 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- National Research Corporation ebitda for the quarter ending March 31, 2026 was 7.7 M, a 23.67% decrease year-over-year.
- National Research Corporation ebitda for the twelve months ending March 31, 2026 was 31.1 M, a 25.18% decrease year-over-year.
- National Research Corporation annual ebitda for 2025 was 30.2 M, a 26.69% decrease from 2024.
- National Research Corporation annual ebitda for 2024 was 41.2 M, a 10.29% decrease from 2023.
- National Research Corporation annual ebitda for 2023 was 45.9 M, a 5.41% decrease from 2019.
- National Research Corporation annual ebitda for 2019 was 48.6 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
National Research Corporation EBITDA — FAQ
National Research Corporation (NRC) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NRC's ebitda history?
The chart and table above show National Research Corporation's ebitda by year and by quarter, including the growth rate.